Morgan Jones, MS, CCC-SLP | |
2203 Highway 72 E, Corinth, MS 38834-8859 | |
(662) 872-3177 | |
Not Available |
Full Name | Morgan Jones |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 2203 Highway 72 E, Corinth, Mississippi |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760090104 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 5899 (Tennessee) | Secondary |
235Z00000X | Speech-language Pathologist | S4287 (Mississippi) | Primary |
Provider Name | King Speech-language Therapy, Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1467964536 PECOS PAC ID: 6901169291 Enrollment ID: O20180419002114 |
News Archive
Only about 1 in 4 Americans aged 50-64 regularly take advantage of preventive services such as screenings and immunizations, according to a report from the Centers for Disease Control and Prevention in collaboration with AARP and the American Medical Association (AMA).
Ore Pharmaceutical Holdings Inc., announced today the filing of a Form 15 with the Securities and Exchange Commission (the "SEC"). Ore filed the Form 15 with the SEC in order to effect a termination of the registration of its common stock under the Securities Exchange Act of 1934.
Children with trisomy 13 or 18, who are for the most part severely disabled and have a very short life expectancy, and their families lead a life that is happy and rewarding overall, contrary to the usually gloomy predictions made by the medical community at the time of diagnosis, according to a study of parents who are members of support groups published today in Pediatrics.
A retrospective review of several thousand melanoma cases in North Carolina found that Medicaid patients were more likely to experience surgical treatment delays than patients with private insurance, according to a study by University of North Carolina Lineberger Comprehensive Cancer Center researchers.
Allergan plc, a leading global pharmaceutical company, today announced that it has launched a generic version of Janssen's INVEGA (paliperidone extended-release tablets) in the U.S. Allergan is the first company to receive FDA approval for and launch a generic version of INVEGA, demonstrating the deep expertise of the Company's global generics R&D, regulatory and supply chain teams.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Morgan Jones, MS, CCC-SLP 2203 Highway 72 E, Corinth, MS 38834-8859 Ph: () - | Morgan Jones, MS, CCC-SLP 2203 Highway 72 E, Corinth, MS 38834-8859 Ph: (662) 872-3177 |
News Archive
Only about 1 in 4 Americans aged 50-64 regularly take advantage of preventive services such as screenings and immunizations, according to a report from the Centers for Disease Control and Prevention in collaboration with AARP and the American Medical Association (AMA).
Ore Pharmaceutical Holdings Inc., announced today the filing of a Form 15 with the Securities and Exchange Commission (the "SEC"). Ore filed the Form 15 with the SEC in order to effect a termination of the registration of its common stock under the Securities Exchange Act of 1934.
Children with trisomy 13 or 18, who are for the most part severely disabled and have a very short life expectancy, and their families lead a life that is happy and rewarding overall, contrary to the usually gloomy predictions made by the medical community at the time of diagnosis, according to a study of parents who are members of support groups published today in Pediatrics.
A retrospective review of several thousand melanoma cases in North Carolina found that Medicaid patients were more likely to experience surgical treatment delays than patients with private insurance, according to a study by University of North Carolina Lineberger Comprehensive Cancer Center researchers.
Allergan plc, a leading global pharmaceutical company, today announced that it has launched a generic version of Janssen's INVEGA (paliperidone extended-release tablets) in the U.S. Allergan is the first company to receive FDA approval for and launch a generic version of INVEGA, demonstrating the deep expertise of the Company's global generics R&D, regulatory and supply chain teams.
› Verified 3 days ago
Ashlee Lucinda Manahan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 S. Tate St., Suite E, Corinth, MS 38834 Phone: 622-643-4043 | |
Catherine Grace Pratt, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2203 Highway 72 E, Corinth, MS 38834 Phone: 662-872-3177 Fax: 662-872-3117 | |
Samantha Briggs, M.S., CF-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2203 Highway 72 E, Corinth, MS 38834 Phone: 662-872-3177 | |
Mrs. Ruth A King, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1681 Viginia Lane, Corinth, MS 38834 Phone: 662-287-5662 Fax: 662-287-5663 | |
Emily Earnest Sanderson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 S Tate St Ste E, Corinth, MS 38834 Phone: 662-643-4043 Fax: 662-643-4044 | |
Kaylee Crump, M.S. SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 S Tate St Ste E, Corinth, MS 38834 Phone: 662-643-4043 Fax: 662-643-4044 | |
Ivy Robbins, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 S Tate St Ste E, Corinth, MS 38834 Phone: 662-643-4043 Fax: 662-643-4044 |